Interferon alpha in the therapy of CML

M. Talpaz; H. Kantarjian; R. Kurzrock; J. U. Gutterman

doi:10.1111/j.1365-2141.1991.tb08117.x

Interferon alpha in the therapy of CML

M. Talpaz, H. Kantarjian, R. Kurzrock, J. U. Gutterman

Leukemia

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

This paper summarizes the experience with interferon alpha (IFNα) as single‐agent therapy and in combination gathered at M. D. Anderson Cancer Center. It also covers some of the laboratory research associated with these clinical studies.

Original language	English (US)
Pages (from-to)	38-41
Number of pages	4
Journal	British Journal of Haematology
Volume	79
DOIs	https://doi.org/10.1111/j.1365-2141.1991.tb08117.x
State	Published - Oct 1991

ASJC Scopus subject areas

Hematology

Access to Document

10.1111/j.1365-2141.1991.tb08117.x

Cite this

@article{d3268b97f8da4673b01d2b8dbd12d06f,

title = "Interferon alpha in the therapy of CML",

abstract = "This paper summarizes the experience with interferon alpha (IFNα) as single‐agent therapy and in combination gathered at M. D. Anderson Cancer Center. It also covers some of the laboratory research associated with these clinical studies.",

author = "M. Talpaz and H. Kantarjian and R. Kurzrock and Gutterman, {J. U.}",

year = "1991",

month = oct,

doi = "10.1111/j.1365-2141.1991.tb08117.x",

language = "English (US)",

volume = "79",

pages = "38--41",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Interferon alpha in the therapy of CML

AU - Talpaz, M.

AU - Kantarjian, H.

AU - Kurzrock, R.

AU - Gutterman, J. U.

PY - 1991/10

Y1 - 1991/10

N2 - This paper summarizes the experience with interferon alpha (IFNα) as single‐agent therapy and in combination gathered at M. D. Anderson Cancer Center. It also covers some of the laboratory research associated with these clinical studies.

AB - This paper summarizes the experience with interferon alpha (IFNα) as single‐agent therapy and in combination gathered at M. D. Anderson Cancer Center. It also covers some of the laboratory research associated with these clinical studies.

UR - http://www.scopus.com/inward/record.url?scp=0026051441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026051441&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.1991.tb08117.x

DO - 10.1111/j.1365-2141.1991.tb08117.x

M3 - Article

C2 - 1931707

AN - SCOPUS:0026051441

SN - 0007-1048

VL - 79

SP - 38

EP - 41

JO - British Journal of Haematology

JF - British Journal of Haematology

ER -

Interferon alpha in the therapy of CML

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this